NEPH übertreffen die 15 der letzten 26Schätzungen.
58%
Nächster Bericht
Datum des nächsten Berichts
04. März 2026
Estimate forQ4 25(Revenue/ EPS)
$4.54M
/
$0.01
Implizierte Änderung vonQ3 25(Revenue/ EPS)
-4.70%
/
-66.67%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+17.31%
/
-66.67%
Nephros Inc. earnings per share and revenue
On 06. Nov. 2025, NEPH reported earnings of 0.03 USD per share (EPS) for Q3 25, beating the estimate of -0.02 USD, resulting in a 247.06% surprise. Revenue reached 4.76 million, compared to an expected 3.94 million, with a 20.80% difference. The market reacted with a -11.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.01 USD, with revenue projected to reach 4.54 million USD, implying an decrease of -66.67% EPS, and decrease of -4.70% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
FAQ
What were Nephros Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Nephros Inc. reported EPS of $0.03, beating estimates by 247.06%, and revenue of $4.76M, 20.8% above expectations.
How did the market react to Nephros Inc.'s Q3 2025 earnings?
The stock price moved down -11.54%, changed from $5.20 before the earnings release to $4.60 the day after.
When is Nephros Inc. expected to report next?
The next earning report is scheduled for 04. März 2026.
What are the forecasts for Nephros Inc.'s next earnings report?
Based on 4
analysts, Nephros Inc. is expected to report EPS of $0.01 and revenue of $4.54M for Q4 2025.